High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

PURPOSE: Until now, most long-term results for brachytherapy only has been published for low-dose-rate (LDR) seeds. Due to radiobiology reasons, high-dose-rate (HDR) mono-brachytherapy is of growing interest. The aim of the study was to report long-term biochemical control rate and toxicities with H...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Bengt, Olsén, Johan Staby, Karlsson, Leif, Lundin, Erik, Lennernäs, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170525/
https://www.ncbi.nlm.nih.gov/pubmed/34122563
http://dx.doi.org/10.5114/jcb.2021.105846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170525/
https://www.ncbi.nlm.nih.gov/pubmed/34122563
http://dx.doi.org/10.5114/jcb.2021.105846

Ejemplares similares